Phase II study of the clinical efficacy and safety of tosedostat in patients with myelodysplastic syndromes (MDS) after failure of hypomethylating agent-based therapySang‐Min Lee, Gail J. Roboz, Tania J. Curcio et al.|Leukemia & lymphoma/Leukemia and lymphoma|2020Cited by 3
Phase II Clinical Study of the Clinical Efficacy and Safety of Tosedostat in Patients with Myelodysplastic Syndromes (MDS) after Failure of Hypomethylating Agent-Based TherapySangmin Lee, Gail J. Roboz, Pinkal Desai et al.|Blood|2017Cited by 1